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Abstract
Background and Aims: Histological and rapid urease tests to detect H. pylori in biopsy specimens obtained during peptic
ulcer bleeding episodes (PUB) often produce false-negative results. We aimed to examine whether immunohistochemistry
and real-time PCR can improve the sensitivity of these biopsies.
Patients and Methods: We selected 52 histology-negative formalin-fixed paraffin-embedded biopsy specimens obtained
during PUB episodes. Additional tests showed 10 were true negatives and 42 were false negatives. We also selected 17
histology-positive biopsy specimens obtained during PUB to use as controls. We performed immunohistochemistry staining
and real-time PCR for 16S rRNA, ureA, and 23S rRNA for H. pylori genes on all specimens.
Results: All controls were positive for H. pylori on all PCR assays and immunohistochemical staining. Regarding the 52
initially negative biopsies, all PCR tests were significantly more sensitive than immunohistochemical staining (p,0.01).
Sensitivity and specificity were 55% and 80% for 16S rRNA PCR, 43% and 90% for ureA PCR, 41% and 80% for 23S rRNA PCR,
and 7% and 100% for immunohistochemical staining, respectively. Combined analysis of PCR assays for two genes were
significantly more sensitive than ureA or 23S rRNA PCR tests alone (p,0.05) and marginally better than 16S rRNA PCR alone.
The best combination was 16S rRNA+ureA, with a sensitivity of 64% and a specificity of 80%.
Conclusions: Real-time PCR improves the detection of H. pylori infection in histology-negative formalin-fixed paraffin-
embedded biopsy samples obtained during PUB episodes. The low reported prevalence of H. pylori in PUB may be due to
the failure of conventional tests to detect infection.
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Introduction
Peptic ulcer bleeding (PUB) is one of the severest complications
of Helicobacter pylori infection [1]. Eradication therapy effectively
prevents recurrent PUB [2]. However, the reported prevalence of
H. pylori infection in bleeding ulcers is lower than in nonbleeding
ulcers [3]. As tests for H. pylori are less reliable in the setting of
PUB [4], whether this lower prevalence is genuine or merely
reflects the lack of sensitivity of the diagnostic tests is unknown.
Moreover, indirect data suggest that conventional tests may also
fail to detect H. pylori in other settings; for example, H. pylori
‘‘negative’’ MALT lymphomas have been reported to heal after
eradication treatment [5]. In one study of the bacterial microbiota
in the human stomach, polymerase chain reaction (PCR) detected
H. pylori infection in gastric samples from 19 of 23 subjects;
however, only 12 of these were positive on conventional tests [6].
Thus, highly sensitive molecular approaches might help detect H.
pylori in settings such as PUB, gastric cancer, or MALT lymphoma
in which H. pylori diagnosis is important but elusive.
Real-time PCR is a sensitive, accurate method of diagnosing H.
pylori infection. Compared to other available methods for
diagnosing H. pylori for clinical and research purposes, PCR yields
high sensitivity and specificity for H. pylori in frozen samples from
patients with nonbleeding peptic ulcer [7,8]. PCR is also far better
than histology at detecting H. pylori in fresh frozen gastric biopsies
from PUB patients [9].
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Although fresh or frozen biopsy specimens are the samples of
choice for nucleic acid extraction, they require specialized storage
and are rarely obtained in clinical practice. Formalin-fixed
paraffin-embedded (FFPE) samples are the most widely available
material for retrospective clinical studies. Given their potential for
genomic analysis, these tissues represent an invaluable resource for
research. DNA extracted from FFPE samples can also be used as a
target for PCR: several experiments have confirmed that
amplifying small PCR products is highly efficient and specific for
detecting H. pylori [10,11]. In this context, PCR for H. pylori in
FFPE biopsies has proven reasonably accurate [11,12]. Nonethe-
less, the best genes to detect H. pylori infection in FFPE biopsies
have not been established. Potential candidates are 16S ribosomal
RNA (16S rRNA) [13], ureaseA (ureA) [14], and 23S ribosomal
RNA (23S rRNA) genes [15].
In a previous study, we found that biopsies obtained during the
initial endoscopy were negative for H. pylori at histology in 25% of
patients (58 of 232) with PUB. However, 82% of the 52 patients
who underwent a delayed [13C]-urea breath test (UBT) four to
eight weeks after bleeding had evidence of infection, so the final
prevalence of H. pylori infection approached 100% [16]. Other
authors have reported similar findings on delayed tests [17–19],
confirming the low sensitivity and negative predictive values of
conventional H. pylori tests during acute upper gastrointestinal
bleeding. Overall, these studies suggest that ‘‘idiopathic’’ bleeding
ulcers may be less common than previously reported [3].
The aim of the present study was to evaluate the potential
usefulness of real-time PCR for improving detection of H. pylori
infection in false-negative FFPE samples from patients with PUB.
A secondary objective was to compare the sensitivity of different
PCR targets and immunohistochemical staining for the detection
of H. pylori.
Methods
Ethics Statement
The Ethics Committee of the Hospital de Sabadell approved the
research protocol. Samples of control patients were prospectively
obtained and both positive and negative control patients gave
written informed consent to participate in the study. Regarding
PUB cases, the patients were identified from a retrospective study
and the samples obtained from the paraffin-embedded biopsy
samples stored in the Pathology Department of the Hospital. In
these patients, informed consent was not obtained in accordance
with the Spanish Law 14/2007 of Biomedical Research.
According to the law, archive samples may be used for biomedical
research without informed consent when obtaining informed
consent is not possible or extremely difficult, provided that a) the
investigation performed is of general interest, b) there is no
previous declaration of the patient against the use of the samples
for research, c) data confidentiality is granted and d) the Ethics
Committee of the Hospital evaluates and approves the study
protocol.
Patients
We initially used histology to select H. pylori-negative antral
biopsy specimens obtained during acute PUB during emergency
endoscopy in 58 patients; six patients did not complete follow-up
and their samples were excluded from the analysis. Of the
remaining 52 patients, 42 were positive and 10 were negative for
H. pylori on a [13C]-UBT performed four to eight weeks after PUB.
Antibiotics were stopped at least four weeks and proton pump
inhibitors (PPI) at least two weeks before the [13C]-UBT. We
included 17 histologically positive samples from patients with PUB
as positive controls. This 69 patients (52 men and 17 women;
mean age, 61.5615.8 years; range, 22–90 years) were included
between January 1995 and September 2000. They were selected
from a large retrospective series of PUB patients followed up at the
Digestive Diseases Department of the Hospital de Sabadell [16].
All patients were administered intravenous omeprazole after
admission and underwent urgent upper gastrointestinal endoscopy
in the first 24 hours to diagnose and treat the bleeding. All the
biopsy samples analyzed in this study were obtained in this initial
procedure. Table 1 shows the characteristics of the patients
included in the study.
We also selected 32 negative controls from a larger series of
patients with dyspeptic symptoms who underwent endoscopy
between 2006 and 2009 [20,21]. In all patients, PPIs were avoided
for at least two weeks and antibiotics stopped at least four weeks
before endoscopy. To ensure that controls were truly uninfected,
we included only those with strictly normal histological findings,
including the absence of indirect histological signs of H. pylori
infection such as lymphoid follicles or acute or chronic gastritis;
moreover, all controls had no evidence of H. pylori on the rapid
urease, UBT, and fecal tests.
DNA Extraction
We retrieved FFPE gastric biopsy specimens collected at initial
endoscopy from the Pathology Department’s archives. Three
10 mm-thick sections were cut from each specimen and placed in a
1.5 ml polypropylene tube (Eppendorf, Hamburg, Germany).
Every paraffin block contained from one to five antral biopsies.
DNA was extracted as described by Chomczynski and Sacchi [22].
Briefly, paraffin was removed by washing three times with 1 ml of
xylene for 5 minutes, followed by rehydration through three
washes with 100% ethanol and two washes with 70% ethanol.
Table 1. Characteristics of PUB patients.
Hp (+) patients (n =17) Hp (2) patients (n =52) Hp (2) controls (n=32)
Gender (Male/Female) (n) 16/1 36/16 13/19
Age (Years) 53.4614 64.2615 45.8616
Endoscopic diagnosis (n)
Duodenal ulcer 14 26 -
Gastric ulcer 2 24 -
Erosive gastritis/duodenitis 1 2 -
Blood in stomach (yes/no/not specified) 5/12/0 6/43/3 -
doi:10.1371/journal.pone.0020009.t001
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After each step, the tissue was collected by centrifugation at
160006 g for 3 minutes. After the final 70% ethanol wash, the
pellet was resuspended in 300 ml of lysis buffer containing
100 mmol/L sodium chloride, 10 mmol/L Tris/HCl (pH 8.0),
25 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.5% sodi-
um dodecyl sulfate (Applichem, Darmstadt, Germany), and
100 mg/ml proteinase K (Roche Applied Science, Mannheim,
Germany) and incubated at 50uC overnight until tissue was
completely solubilized. DNA was purified by phenol/chloroform/
isoamyl alcohol (25:24:1, vol/vol/vol) followed by precipitation
with 2.5 volumes of isopropanol in the presence of 0.1 volumes of
3 mol/L sodium acetate and 5 mg of linear acrylamide (Ambion,
Austin, USA). The DNA pellet was washed once in 70% ethanol,
dried, and resuspended in 50 ml of 10 mmol/L Tris/HCl (pH 8),
0.1 mmol/L EDTA.
Bacterial strains
To evaluate the specificity of the PCR assays for 16S rRNA,
ureA, and 23S rRNA, 11 bacterial species were grown on
Columbia blood agar supplemented with 5% sheep blood
(Biomerieux, Spain) at 37uC under appropriate atmospheric
conditions. Bacterial species were obtained from clinical isolates
(Staphylococcus epidermidis, Corynebacterium sp., Proteus sp., Candida
albicans, and Neisseria meningitidis) or from the American Type
Culture Collection (ATCC) (Rockville, MD, USA): Pseudomonas
aeruginosa, Enterococcus faecalis, Escherichia coli, Staphylococcus aureus,
Streptococcus pneumoniae and Haemophilus influenzae), and Helicobacter
pylori strains J99 and 26695 (Table 2).
Real-time PCR
TaqMan PCR was used to amplify fragments of the 16S rRNA
and ureA genes, and SyBR Green PCR was used to amplify
fragments of the 23S rRNA gene of H. pylori and the human b-
globin gene. Real-time PCR was carried out in an ABI 7500
thermocycler (Applied Biosystems) with the following thermal
cycling conditions:
a) TaqMan PCR for the 16S rRNA gene: Initial uracil-DNA
glycosylase (UNG) incubation at 37uC for 10 min., followed
by denaturation at 95uC for 10 min., and 40 cycles consisting
of denaturation at 92uC for 15 s. followed by annealing/
extension at 64uC for 1 min.
b) TaqMan PCR for the UreA gene: Initial UNG incubation at
37uC for 10 min., followed by denaturation at 95uC for
10 min., and 40 cycles consisting of denaturation at 95uC for
15 s, touchdown annealing from 60uC to 57uC for 10 s
(temperature decrements, 0.2uC), and extension at 72uC for
35 s.
c) SyBR Green PCR for the 23S rRNA gene of H. pylori: Initial
UNG incubation at 37uC for 10 min., followed by denatur-
ation at 95uC for 10 min, and 45 cycles consisting of
denaturation at 95uC for 30 s, annealing at 60uC for 30 s,
and extension at 72uC for 35 s. After amplification, a melting
step was performed.
The 25 ml PCR reaction mixture was prepared with 12.5 ml of
26SensiMix (dU) (Quantace LTD., London, UK), 0.5 ml of 506
UNG, and 2.5 ml of DNA for all genes. MgCl2 concentrations
were 5.5 mM, 4.0 mM, and 3.0 mM for the 16S rRNA, ureA
,and 23S rRNA genes, respectively. Primer concentrations were
0.1 mM, 0.25 mM, and 0.4 mM for the 16S rRNA, ureA, and 23S
rRNA genes, respectively. The TaqMan probe concentration was
4.0 nM for 16S rRNA and 20 nM for ureA.
TaqMan probes were labeled with the fluorescent dyes 6-
carboxyfluorescein (6-FAM) on the 59 end and with 6-carboxyte-
tramethylrhodamine (TAMRA) on the 39 end; probes were
purified by high performance liquid chromatography. Primers
and probes were purchased from Stabvida Lda. (St. Antonio de
Oeiras, Portugal). Corresponding sequences are listed in Table 3.
Human b-globin amplification
The quality of the DNA isolated from the biopsy specimens was
confirmed by an initial PCR. We used PCR on each DNA extract
to amplify a 110 bp fragment from the b-globin gene region [23].
All tests were performed by two experienced molecular biologists
who were blinded to the H. pylori status of the samples and to the
results of the other tests.
Histological predictors of infection and
immunohistochemical analysis
Two specialized pathologists (AC,ES) who were unaware of
the final H. pylori status analyzed the biopsy specimens and
recorded the presence of active gastritis (yes/no), chronic
gastritis (yes/no), lymphoid aggregates (yes/no), atrophic gastritis
(yes/no), and intestinal metaplasia (yes/no). A specific immuno-
histochemical stain was also performed to ensure that H. pylori
was not microscopically detectable. A 3 mm-thick section from
the same paraffin blocks used for PCR was fixed on adhesive-
coated slides. Specimens were incubated with primary antibody
(polyclonal rabbit anti-Helicobacter pylori) at a dilution 1/500, and
biopsies were immunohistochemically stained with H. pylori
antibodies using the EnvisionTM Flex/Hrp technique. Primary
and secondary antibodies were purchased from Dako (Glostrup,
Denmark).
Statistical analyses
The three PCR methods were validated by PCR analysis of the
three PCR primers in the 17 positive controls and in the 32
negative controls.
The prevalence of H. pylori infection determined by the different
PCR methods is reported as percentage (95% confidence intervals)
for the individual PCR techniques and for combinations of two or
Table 2. Species specificity of PCR for H. pylori.
Bacterial species
Presence (+) or absence (2) of
the following PCR product
16S rRNA ureA 23S rRNA
Staphylococcus epidermidis (Clinical isolate) 2 2 2
Corynebacterium Sp. (Clinical isolate) 2 2 2
Pseudomonas aeruginosa (ATCC 27853) 2 2 2
Enterococcus faecalis (ATCC 29212) 2 2 2
Escherichia coli (ATCC 25922) 2 2 2
Staphylococcus aureus (ATCC 29213) 2 2 2
Proteus sp. (Clinical isolate) 2 2 2
Candida albicans (Clinical isolate) 2 2 2
Streptococcus pneumoniae (ATCC 7214) 2 2 2
Haemophilus influenzae (ATCC 49247) 2 2 2
Neisseria meningitidis (Clinical isolate) 2 2 2
Helicobacter pylori (ATCC 700824) + + +
Helicobacter pylori (ATCC 700392) + + +
doi:10.1371/journal.pone.0020009.t002
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more techniques. In the 52 patients with further follow-up, we
calculated the sensitivity, specificity, positive predictive values
(PPV), and negative predictive values (NPV) together with their
95% confidence intervals for the histological parameters and
different PCR methods, using the results of the delayed UBT as
the gold standard. Sensitivities and specificities were compared
using the McNemar test as described by Biswas [24]. We used the
chi-square test to analyze differences in proportions between
groups. We used SPSS 15.0.1 for Windows (SPSS Inc. Chicago,
IL) for all analyses. Significance was set at p,0.05.
Results
Species specificity of the PCR assay
All DNA derived from non-Helicobacter species was negative for
all three PCR products; the two strains of H. pylori were positive for
all three products. Table 2 summarizes these results.
Validation of PCR assays
All the antral biopsy specimens from the 17 positive controls
were positive on all three PCR assays. All the antral biopsy
specimens from the 32 negative controls were negative on all three
PCR assays, except those from one patient, which were positive for
ureA and those from another patient, which were positive for all
three genes thus raising the possibility of occult infection
undetected by conventional methods.
All samples were positive for b-globin amplification, indicating
that no PCR inhibitors were present.
Prevalence of infection according to the different
methods
Real-time PCR was positive for 16S rRNA in 25 of the 52
patients (48%) and for both UreA and 23S rRNA in 19 of 52
(37%). Immunohistochemical analysis detected the infection in
only three (6%) of the patients. The sensitivity, specificity, PPV,
and NPV for the PCR assays and immunohistochemical staining
in this group with respect to the delayed UBT gold standards are
reported in Table 4. We found no association between the number
of biopsies in the paraffin block and the rate of H. pylori detection
by PCR.
The sensitivity of all PCR assays was significantly higher than
that of immunohistochemical staining, with p values ranging from
0.01 to ,0.001. No significant differences were observed,
however, between PCR assays. Furthermore, the number of
‘‘true’’ H. pylori-negative cases was too low to enable statistical
comparison of the specificities. All combinations of PCR tests
improved the sensitivity but slightly decreased the specificity
(Table 4). All PCR combinations were significantly more sensitive
than the ureA PCR test alone (p,0.05) or the 23S rRNA PCR test
alone (p,0.05) and marginally better than the 16S rRNA test
alone. No significant differences were observed between combi-
nations of PCR tests.
In addition, we evaluated the predictive value of the different
histological parameters for H. pylori infection (Table 5). The
presence of acute gastritis was the only histological parameter with
acceptable sensitivity and specificity for detecting active H. pylori
infection.
Table 3. Primers and probes used to amplify the target genes.
Gene Forward primer Reverse primer Length (bp) Ref.
16S rRNA 59-ctc att gcg aag gcg acc t-39 59-tct aat cct gtt tgc tcc cca-39 76 [13]
ureA 59-cgt ggc aag cat gat cca t-39 59-ggg tat gca cgg tta cga gtt t-39 77 [14]
23S rRNA 59-gga gct gtc tca acc aga gat tc-39 59-cgc atg ata ttc cca tta gca g-39 132 [15]
Human b-globin 59-aca caa ctg tgt tca cta gc-39 59-caa ctt cat cca cgt tca cc-39 110 [23]
TaqMan probe Sequence
16S rRNA 59- (6-FAM)-att act gac gct gat tgc gcg aaa gc-TAMRA- 39
ureA 59- (6-FAM)-tca gga aac atc gct tca ata ccc act t-TAMRA-39
(bp): base pairs.
doi:10.1371/journal.pone.0020009.t003
Table 4. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio, and
negative likelihood ratio of H. pylori diagnostic tests in histology-negative PUB patients.
Sensitivity(%)
(95% CI)
Specificity(%)
(95% CI)
PPV (%)
(95% CI)
NPV (%)
(95% CI)
(+) Likelihood
ratio
(2) Likelihood
ratio
Immunohistochemistry 7 (2%–19%) 100 (66%–100%) 100 (31%–99%) 20 (11%–35%) ‘ 0.93
16S rRNA 55 (39%–70%) 80 (44%–96%) 92 (73%–99%) 30 (14%–50%) 2.75 0.56
ureA 43 (28%–59%) 90 (54%–99%) 95 (72%–99%) 29 (15%–48%) 4.3 0.63
23S rRNA 41 (26%–57%) 80 (44%–96%) 90 (65%–98%) 24 (12%–43%) 2.05 1.12
16S rRNA + ureA 64 (48%–78%) 80 (44%–96%) 93 (76%–99%) 35 (17%–57%) 3.2 0.45
16S rRNA + 23S rRNA 60 (43%–74%) 60 (27%–86%) 86 (67%–95%) 26 (11%–49%) 1.5 0.66
ureA + 23S rRNA 57 (41%–72%) 70 (35%–92%) 89 (70%–97%) 28 (13%–50%) 1.9 0.61
16S rRNA + ureA + 23S rRNA 67 (50%–80%) 60 (27%–86%) 88 (70%–96%) 30 (13%–54%) 1.67 0.55
doi:10.1371/journal.pone.0020009.t004
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Discussion
We found that real-time PCR detects H. pylori in more than 2/3
of the histology-negative sample, being far more sensitive than
conventional histological identification of the bacteria or immu-
nohistochemistry and may be a useful alternative for detecting H.
pylori infection in patients with PUB. The real-time PCR described
here has the additional advantage that it can be used in FFPE
samples, allowing detection of H. pylori in both prospective and
retrospective studies.
In addition to showing that PCR is useful in the acute PUB
setting, our study gives support to the recently challenged [25]
classical view that even a small number of polymorphonuclear
neutrophils in a gastric biopsy is an almost certain indicator of
active H. pylori infection [26]. In PUB patients this affirmation
holds true even when the bacteria are not detectable by direct
visualization or immunohistochemistry. For this reason, the
finding of acute inflammation in biopsies negative for H. pylori
should prompt additional studies.
Our findings confirm that H. pylori infection is elusive in PUB.
Studies of H. pylori diagnostic methods in patients with PUB have
found 25% to 50% false-negative results for histological study of
biopsies obtained during bleeding episodes [4,27]. Consequently,
current guidelines recommend either more sensitive diagnostic
analysis or delayed testing to rule out the infection [28].
Although there is no fully accepted explanation for the reduced
reliability of diagnostic tests for H. pylori in the PUB setting, various
factors could lead to a transient decrease in bacterial density that
would make detection more difficult. First, due to the bactericidal
effects of serum, the presence of blood in the stomach would
directly lower bacterial density [29,30]. Second, the accuracy of
the rapid urease test in the PUB setting could also be affected by
the presence of albumin in the gastric lumen, which could prevent
color change by acting as a buffer on the pH indicator [31]. Third,
these patients are often taking PPIs, which could reduce the
bacterial load [32]. Finally, large-volume gastric rinsing before
endoscopy may result in temporary removal of the bacteria [33].
In comparison with other invasive techniques, PCR provides
very sensitive and accurate diagnosis of H. pylori in patients with
non-bleeding peptic ulcers [13,34]. However, few studies have
examined the diagnostic accuracy of PCR in patients with PUB
[9,35,36]. Most of them indicate that PCR is more sensitive than
other tests for H. pylori in PUB, though they did not evaluate real-
time PCR or use FFPE biopsies. Real-time PCR has several
advantages over conventional PCR, such as short working time,
high specificity, and low risk of cross contamination. However,
because of the diversity of the H. pylori genome, the choice of
specific primers is of paramount importance. We used PCR for a
small part of the 16S rRNA, ureA, and 23S rRNA genes, which
have been reported to be highly sensitive and specific and are well
preserved in FFPE samples [13–15]. Our results indicate that the
most accurate PCR test for H. pylori in PUB patients is either the
combination of 16S rRNA and ureA (sensitivity, specificity, PPV,
and NPV of 64%, 80%, 93%, and 35%, respectively) or the
combination of all three targets (sensitivity, specificity, PPV, and
NPV of 67%, 60%, 88%, and 30%, respectively).
Because real-time PCR is based on DNA detection and does not
require viable bacteria, it is a useful adjunct to culturing, the gold
standard in the diagnosis of H. pylori, especially when antimicrobial
treatment has already started [37]. Real–time PCR is inexpensive;
indeed, it is less expensive than histology. Thus, the cost of using
real-time PCR in patients negative for H. pylori at histology will
likely be compensated by the clinical benefits derived from
detecting the infection in a significant percentage of histologically
negative biopsies. Furthermore, PCR techniques have been
progressively incorporated into the routine workload of microbi-
ology units, and some PCR tests are already routine in clinical
practice. Thus, incorporating real-time PCR tests into the routine
work-up for histologically negative biopsies from patients with
PUB seems feasible.
The present study casts doubt on the suggestion that the
prevalence of H. pylori in bleeding ulcers is lower than in non-
bleeding ones [3,38–42]. Some studies have even reported a rising
prevalence of idiopathic ulcers [43]. However, few of these studies
used delayed tests for H. pylori or PCR methods. As PCR detected
H. pylori in more than two-thirds of the histology-negative biopsies
in our series, it is reasonable to wonder how many of the
‘‘idiopathic’’ PUB found in previous studies were actually under-
diagnosed H. pylori-related PUB. The true prevalence of idiopathic
ulcers and idiopathic PUB remains to be determined.
Some points of the study deserve specific comment: First,
although the sensitivity of PCR (range 41%–67%) may appear
low, it is important to take into account that the biopsies studied
were negative for H. pylori at histology. Thus, not only did PCR
detect H. pylori in all the histology-positive control biopsies, it also
detected H. pylori in two-thirds of the histology-negative samples
from patients with a positive delayed 13C-UBT [16]. Likewise,
although the specificity may seem relatively low, there is no perfect
gold standard for H. pylori and there are no techniques able to
detect all cases of infection. Thus, as real-time PCR is highly
sensitive, it is quite possible that at least one of the patients
considered false-positives of PCR were, in fact, infected and would
therefore be false-negatives of the delayed 13C-UBT we used as a
gold-standard.
This study deals with a selected subpopulation of PUB patients
with initially negative histological findings. In our environment,
these patients are rare and therefore difficult to recruit. This
explains our limited sample size and consequently the wide 95%
Table 5. Sensitivity, specificity, positive (PPV) and negative (NPV) predictive values, and positive and negative likelihood ratios of
histopathological parameters for the diagnostic of infection in H. pylori negative biopsies in PUB patients.
Sensitivity(%)
(95% CI)
Specificity(%)
(95% CI)
PPV (%)
(95% CI)
NPV (%)
(95% CI)
(+) Likelihood
ratio
(2) Likelihood
ratio
Acute gastritis 76 (60%–87%) 80 (44%–96%) 94 (79%–99%) 49 (32%–66%) 3.8 0.3
Chronic gastritis 97 (74%–100%) 20 (10%–36%) 83 (47%–97%) 67 (13%–98%) 1.21 0.15
Lymphoid follicles 67 (50%–80%) 50 (20%–80%) 85 (67%–94%) 26 (10%–51%) 1.34 0.66
Atrophy 50 (34%–65%) 30 (8%–65%) 88 (66%–96%) 25 (11%–45%) 0.71 1.67
Metaplasia 36 (19%–56%) 60 (27%–86%) 71 (47%–87%) 13 (4%–31%) 0.9 1.07
doi:10.1371/journal.pone.0020009.t005
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CI for the sensitivity of PCR (around 615%). Nevertheless, the
sample size is large enough to demonstrate that PCR is far more
sensitive than histology or immunohistochemistry and that the best
results are observed when two or three genes are targeted.
A final point is that we evaluated only antral biopsy specimens.
Gisbert et al. [2] suggested that histological examination of
specimens from both the antrum and corpus improved diagnostic
sensitivity from 70% to 83%. However, a previous study [16]
found no significant benefit for the combination of antral and
corpus biopsies. In the present study, no corpus samples were
available for PCR analysis, so we could not analyze the potential
usefulness of PCR or immunohistochemical study of biopsy
specimens from the corpus.
Our results raise diverse questions for further research. The
prevalence of H. pylori infection is high in southern Europe, both in
the general population and in PUB patients [44,45]; it would be
interesting to know whether our results could be confirmed in low-
prevalence areas like northern Europe, Canada, or some parts of
the United States. It would also be interesting to evaluate whether
real-time PCR is useful for detecting H. pylori in other scenarios
where the infection is often elusive, such as in patients with low-
grade gastric MALT lymphoma or gastric cancer or even in those
with uncomplicated ulcer or dyspepsia receiving PPI before
endoscopy. Finally, it would be interesting to compare real-time
PCR with conventional tests in an unselected population of
dyspeptic patients.
In conclusion, our study shows that real-time PCR improves the
detection of H. pylori in FFPE biopsies in PUB patients and can be
used to identify H. pylori infection in patients with negative
histological findings. Our results support previous data that suggest
that a significant percentage of ‘‘idiopathic’’ bleeding ulcers may
actually be false-negative results of conventional tests to detect H.
pylori.
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